Sodium Tetradecyl Sulfate (Sotradecol)

07/01/1995 - "At first, the varices were treated successfully with sodium tetradecyl sulfate and bleeding stopped. "
06/01/2013 - "Bleeding from focal varices in the stoma (with the rest of the stomal mucosa looking normal and not engorged) can be treated with TIPS (if the portal or mesenteric vein or both are patent) or with transvenous obliteration utilizing 1% sodium tetradecyl sulfate (not 3% sodium tetradecyl sulfate). "
07/01/2011 - "Obliteration of bleeding peristomal varices with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam."
03/01/2011 - "Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam."
01/01/1980 - "PTEV, using Gel-Foam soaked in sodium tetradecyl sulfate, controlled acute variceal bleeding in 71--95% of patients and appears to be more effective as an embolizing agent than bucrylate, which controlled 43--57%. "

09/01/2012 - "When used in appropriate doses, Sclerosing agent, 3% sodium tetradecyl sulfate (STD), is very effective for treatment of oral hemangioma. "
09/01/1997 - "Percutaneous injection of sodium tetradecyl sulfate, either alone or before surgery, is a safe and effective method of managing symptomatic hemangiomas and venous malformations."
09/01/2012 - "Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases."
08/01/2007 - "The authors also review treatment modalities and demonstrate the utility and effectiveness of intraoperative sodium tetradecyl sulfate in grosstotal resection of large difficult spinal epidural hemangiomas."
08/01/2007 - "Use of intraoperative sodium tetradecyl sulfate for the treatment of a spinal epidural hemangioma. "

12/01/2014 - "The purpose of the study is to determine the effectiveness of transvenous obliteration using sodium tetradecyl sulfate (STS) and to describe a new simplified technique in obliterating these varices. "
03/01/1948 - "The use of sodium tetradecyl sulfate in the sclerosing treatment of varicose veins; an experimental and clinical study."
10/01/2007 - "Sodium tetradecyl sulfate is a sclerosing agent that has been widely used to treat varicose veins of the legs and digestive tract. "
11/01/2004 - "A mean number of 2.15 treatments utilizing an average of 8.37 mL of foam sclerosing solution (3% sodium tetradecyl sulfate) were required to close all incompetent varicose veins in the < 10-mm group versus a mean of 2.8 treatments and 13.9 mL foam (3% sodium tetradecyl sulfate) for the > or =10-mm group. "
01/01/1988 - "Sotradecol--sodium tetradecyl sulfate--is a sclerosing agent which has been used for years in the treatment of varicose veins, haemorrhoids and haemangiomata. "

11/01/2014 - "Intralesional sodium tetradecyl sulfate injection is a simple, safe, and effective modality for distal mucous cyst. "
01/01/1989 - "Mucoid cysts of the fingers and toes may be cured by injection of a sclerosant such as sodium tetradecyl sulfate. "
11/01/2014 - "At each session, 1% to 3% sodium tetradecyl sulfate of 0.2 to 0.5 mL was injected into a lesion and repeated every 4 weeks if the cyst persisted. "
11/01/2014 - "Treatment of digital mucous cysts with intralesional sodium tetradecyl sulfate injection."
10/01/2007 - "A 5-French catheter was coaxially placed for fluoroscopic contrast cyst definition and subsequent dual drug chemical ablation (sodium tetradecyl sulfate and ethanol). "

02/01/2008 - "To report the results of treatment of adolescent patients with varicocele with use of 3% sodium tetradecyl sulfate foam (STS) in combination with pushable fibered coils. "
02/01/2008 - "Initial experience with 3% sodium tetradecyl sulfate foam and fibered coils for management of adolescent varicocele."
10/01/2014 - "To assess the efficacy of stop-flow foam sclerotherapy (SFFS) in high-flow pelvic varicoceles using 3 % sodium tetradecyl sulfate (STS) foam. "
07/01/2008 - "To evaluate the efficacy of transcatheter foam sclerotherapy (TCFS) in pelvic varicocele using sodium-tetradecyl-sulfate foam (STSF), we conducted a retrospective study in 38 patients (mean age, 36.9 years; range, 22-44 years) with pelvic congestion syndrome (PCS) treated between January 2000 and June 2005 by TCFS. "
07/01/2008 - "Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam."